Advertisement

Veterinary Research Communications

, Volume 31, Issue 7, pp 873–879 | Cite as

Disposition Kinetics, Urinary Excretion and Dosage Regimen of Levofloxacin Formulation Following Single Intravenous Administration in Crossbred Calves

  • V. K. Dumka
  • A. K. Srivastava
Short Communication

Keywords

calves dosage levofloxacin kinetics urinary excretion 

Abbreviations

ATCC

American type culture collection

MIC

minimum inhibitory concentration

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahanger, A.A., Srivastava, A.K. and Raina, R., 2003. Disposition kinetics of enrofloxacin in crossbred calves. Journal of Veterinary Pharmacology and Toxicology, 3, 16–20Google Scholar
  2. Amsden, G.W., Graci, D.M., Cabelus, L.J. and Hejmanowski, L.G., 1999. A randomized, crossover design study of the pharmacology of extended-spectrum fluoroquinolones for pneumococcal infections. Chest, 116, 115–119PubMedCrossRefGoogle Scholar
  3. Arret, B., Johnson, D.P. and Krishbaum, A., 1971. Outline of details for microbiological assay of antibiotics: second revision. Journal of Pharmaceutical Science, 60, 1689–1694CrossRefGoogle Scholar
  4. Atef, M., El-Gendi, A.Y., Aziza Amer, M.M. and El Aty, A.M., 2001. Some pharmacokinetic data for danofloxacin in healthy goats. Veterinary Research Communications, 25, 367–377PubMedCrossRefGoogle Scholar
  5. Baggot, J.D., 1977. Principles of Drug Disposition in Domestic Animals, (W.B. Saunders, Philadelphia)Google Scholar
  6. Chien, S.C., Chow, A.T. and Rogge, M.C., 1997. Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine. Antimicrobial Agents and Chemotherapy, 41, 1765–1769PubMedGoogle Scholar
  7. Chulavatnatol, S., Chindavijak, B., Vibhagool, A., Wananukul, W., Sriapha, C. and Sirisangtragul, C., 1999. Pharmacokinetics of levofloxacin in healthy Thai male volunteers. Journal of the Medical Association of Thailand, 82, 1127–1135PubMedGoogle Scholar
  8. Davis, R. and Bryson, H.M., 1994. Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs, 47, 677–700PubMedGoogle Scholar
  9. Destache, C.J., Pakiz, C.B., Larsen, C., Owens, H. and Dash, A.K., 2001. Cerebrospinal fluid penetration and pharmacokinetics of levofloxacin in an experimental rabbit meningitis model. Journal of Antimicrobial Chemotherapy, 47, 611PubMedCrossRefGoogle Scholar
  10. Edelstein, P.H., Edelstein, M.A., Lehr, K.H. and Ren, J., 1996. In vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia. Journal of Antimicrobial Chemotherapy, 37, 117–126PubMedCrossRefGoogle Scholar
  11. Gascon, A.R., Campo, E., Hernandez, R.M., Calvo, B., Errasti, J. and Pedraz Munoz, J.L., 2000. Pharmacokinetics of ofloxacin enantiomers after intravenous administration for antibiotic prophylaxis in biliary surgery. Journal of Clinical Pharmacology, 40, 869–874PubMedCrossRefGoogle Scholar
  12. Gibaldi, M. and Perrier, D., 1982. Pharmacokinetics, (Marcel Dekker, New York)Google Scholar
  13. Ito, T., Yano, I., Masuda, S., Hashimoto, Y. and Inui, K., 1999. Distribution characteristics of levofloxacin and grepafloxacin in rat kidney. Pharmacological Research, 16, 534–539CrossRefGoogle Scholar
  14. Klesel, N., Geweniger, K.H., Koletzki, P., Isert, D., Limbert, M., Markus, A., Riess, G., Schramm, H. and Iyer, P., 1995. Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals. Journal of Antimicrobial Chemotherapy, 35, 805–819PubMedCrossRefGoogle Scholar
  15. Langtry, H.D. and Lamb, H.M., 1998. Levofloxacin : its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Drugs, 56, 487–515PubMedCrossRefGoogle Scholar
  16. Mochizuki, K., Ohkubo, S., Torisaki, M., Yamashita, Y., Tanahashi, T., Jin, Y., Okamura, Y. and Tanaka, M., 1994. Intraoccular penetration of oral levofloxacin in rabbits. Nippon Ganka Gakkai Zasshi, 98, 1085–1090PubMedGoogle Scholar
  17. North, D.S., Fish, D.N. and Redington, J.J., 1998. Levofloxacin, a second-generation fluoroquinolone. Pharmacotherapy, 18, 915–935PubMedGoogle Scholar
  18. Verho, M., Malerczyk, V., Damm, D. and Lehr, K.H., 1996. Pharmacokinetics of levofloxacin in comparison to the racemic mixture of ofloxacin in man. Drug Metabolism and Drug Interactions, 13, 57–67PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2007

Authors and Affiliations

  1. 1.Department of Pharmacology and Toxicology, College of Veterinary SciencePunjab Agricultural UniversityLudhianaIndia

Personalised recommendations